RandomPhIIIBRAFTargetThe vsCabozantinibRAIRefractoryDifferentThyroidCa w/BRAFV600Em
Shirin Attarian
- OPEN TO ACCRUAL
trials found matching your search:
Displaying 20 of 295 Results
PhIIIVusolimogeneOderparepvecCombw/NivolumabVsTxPhyChoicePaw/AdvMelProgresAntiPD1&AntiCTLA4ContainTx
Thuy Tran
- OPEN TO ACCRUAL
Random PhIII StudyNeoadj Chemothe Followed SurgeryVSSurgery Alone Pa w/HighRisk RetroPeritoneal Sarc
Thuy Tran
- OPEN TO ACCRUAL
A STUDY TO EVALUATE THE EFFICACY AND SAFETY OF JCELL IN PATIENTS WITH RETINITIS PIGMENTOSA
Mitul Mehta
- OPEN TO ACCRUAL
A Phase 2 Study Assessing Rocatinlimab in uncontrolled Asthma patients.
Richard Lee
- OPEN TO ACCRUAL
Treatment of Meniere s Disease with Nortriptyline-Topiramate Stepwise Regimen: A
Hamid Djalilian
- OPEN TO ACCRUAL
A Phase 3, Double-blind Maintenance Study Assessing Rocatinlimab in Moderate-to-severe AD (ROCKET-AS
Michelle Min
- OPEN TO ACCRUAL
Phase III study to evaluate remibrutinib in patients with generalized myasthenia gravis
Ali Habib
- OPEN TO ACCRUAL
MARITIME-2
Qin Yang
- OPEN TO ACCRUAL
PEDAL
Natasha Mesinkovska
- OPEN TO ACCRUAL
Acute Partial Thickness Burn Study Comparing Transforming Powder Dressing to SOC Dressing
Victor Joe
- OPEN TO ACCRUAL
A prospective, multicenter, single arm, open-label, feasibility study to evaluate the safety
Pengbo Jiang
- OPEN TO ACCRUAL
Anifrolumab A Multicenter, Parallel-group, Double-blind, 2-Arm, Phase III Study
Michelle Min
- OPEN TO ACCRUAL
ph3 IgAN Ravulizumab interventional
Ramy Hanna
- OPEN TO ACCRUAL
Exempt ExpanAcc NonInvas CharacterizationGliomaorTxRelatedChangeUsingFluorineFloretyrosine
Jerica Lomax
- OPEN TO ACCRUAL
PhI/IIa Study64Cu-LNTH-1363S Pa w/Sarcoma or GastrointestinalTract Ca
Shyam Srinivas
- OPEN TO ACCRUAL
PhICA4948ComboW/PembroOvercomeResistanPD-1/PD-L1BlockadMetUrothelialCa
Nataliya Mar
- OPEN TO ACCRUAL
PhI/II Study ofREGN5668 Administered inCombw/Cemiplimab orREGN4018
Jill Tseng
- RA SIGNOFF
Ph II/III Trial of Consolidation Radiation + Immunotherapy for ES-SCLC
Jeremy Harris
- OPEN TO ACCRUAL
A research study to look at how ziltivekimab works compared to placebo in people with a heart attack
Pranav Patel
- OPEN TO ACCRUAL